A.CATALYST NETWORK

ATP BioPharm is an energized start-up biotech company that will soon spin off from Taipei Medical University with a focus on drug development for unmet medical needs. Our company is positioned to deliver a best-in-class small molecule from preclinical to clinical stage. MPT0G211,... Cytena Bioprocess Solutions is a spin-out from a German biotech company and was founded in 2018. We believe the automation and micro technology will bring microbioreactors to a whole new level... National Health Research Institutes (NHRI) wishes to form, or spin off, a biotech company (ABT, the NHRI-New Co) focusing on discovery and development of new drugs for treating patients with genetically defined malignancies for whom no standard treatment option exists. Novel chemical entities at clinical stages will be licensed to ABT. Meanwhile, ABT will build a competitive portfolio focusing on driving oncogenes and drug resistance mechanism. ABT is positioned as a precision oncology company specializing in..